Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company (HZNP) Stock Overview

Explore Horizon Therapeutics Public Limited Company’s financial performance, market position, analyst ratings, and future outlook.

HZNP●NASDAQ
HealthcareDrug Manufacturers - General
$116.30
$0.00(0.00%)
U.S. Market opens in 1h 33m

Horizon Therapeutics Public Limited Company (HZNP)

Meyka AI Score

Z

Key Financials

Market Cap26.6B
P/E Ratio51.01
EPS (TTM)$1.88
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$166.21

HZNP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Horizon Therapeutics Public Limited Company's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HZNP on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $166.21 for the NASDAQ listing.

Key metrics behind Horizon Therapeutics Public Limited Company's NASDAQ-traded stock include a P/E ratio of 51.01 and a market capitalization of 26.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HZNP on the NASDAQ.

Price Performance (NASDAQ: HZNP)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
18.47%
5-Year Change
225.86%
All-Time (Max) Change
1171.04%

Contact Information

https://www.amgen.com
353 1 772 2100
70 St. Stephen’s Green, Dublin, NaN, 2

Company Facts

21,900 Employees
IPO DateJul 28, 2011
CountryIE

Frequently Asked Questions